OSLO, Norway, Sept. 1, 2022 /PRNewswire/ Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced the appointment of Dr. Anders Neijber to the position of Chief Medical Officer
/PRNewswire/ On August 9, 2022, Asieris Pharmaceuticals, a global biopharmaceutical company specializing in the discovery and development of innovative.
/PRNewswire/ Photocure ASA (OSE: PHO) announces that positive data from a Danish population registry study featuring nearly 10,000 bladder cancer patients.
Lower rates of bladder cancer recurrence and progression demonstrated in clinics with a high level of blue light cystoscopy (BLC) use in primary patients Photocure sponsor of the Residents
/PRNewswire/ Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the conclusion of a productive AUA 2022 Conference: the American Urological.